| Literature DB >> 34573304 |
Danilo Cilluffo1,2, Roberta Flavia Chiavetta1, Serena Bivona1,3, Flavia Contino1, Claudia Coronnello4, Salvatore Feo1,3,5, Aldo Di Leonardo1,5, Viviana Barra1.
Abstract
The centromere is a fundamental chromosome structure in which the macro-molecular kinetochore assembles and is bound by spindle microtubules, allowing the segregation of sister chromatids during mitosis. Any alterations in kinetochore assembly or functioning or kinetochore-microtubule attachments jeopardize chromosome stability, leading to aneuploidy, a common feature of cancer cells. The spindle assembly checkpoint (SAC) supervises this process, ensuring a faithful segregation of chromosomes. CENP-E is both a protein of the kinetochore and a crucial component of the SAC required for kinetochore-microtubule capture and stable attachment, as well as congression of chromosomes to the metaphase plate. As the function of CENP-E is restricted to mitosis, its haploinsufficiency has been used to study the induced cell aneuploidy; however, the gene expression profile triggered by CENP-E reduction in normal cells has never been explored. To fill this gap, here we investigated whether a gene network exists that is associated with an siRNA-induced 50% reduction in CENP-E and consequent aneuploidy. Gene expression microarray analyses were performed at early and late timepoints after transfection. Initially, cell cycle regulation and stress response pathways were downregulated, while afterwards pathways involved in epithelial-mesenchymal transition, hypoxia and xenobiotic metabolism were altered. Collectively, our results suggest that CENP-E reduction triggers a gene expression program that recapitulates some features of tumor cells.Entities:
Keywords: CENP-E; aneuploidy; cancer progression; centromere; expression profiling
Mesh:
Year: 2021 PMID: 34573304 PMCID: PMC8466516 DOI: 10.3390/genes12091322
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Genome-wide microarray analysis. Comprehensive gene expression analysis at early (72 h) and late (2 w) timepoints after siRNAs (siCENP-E) transfection of IMR90 cells compared to IMR90 control cells (siGFP). (A) Histogram showing number of genes up or down regulated in each sample. (FC ± 1.4, p-value cutoff ≤ 0.05) (B,C) Biological pathways for DEGs. x-axis represents the percentages of genes or −log10 values (p-value); y-axis represents the Biological pathways significantly enriched using the FunRich bioinformatics tool. (D) Venn diagram set out the number of common up- (top) and down- (bottom) regulated DEGs found in the two samples. (E) Heat map displaying expression levels of significantly common DEGs in trasfected IMR90 cells.
List of common deregulated genes shared by IMR90 siCENP-E at 72 h and 2 weeks with relative Log (Fold Change) values (only annotated probes are reported).
|
| Description | LogFC | # Chr. | Map Location | |
|---|---|---|---|---|---|
| 72 h | 2 Weeks | ||||
| ZG16B | zymogen granule protein 16B | −2.21378 | −1.58077 | 16 | 16p13.3 |
| TFPI2 | tissue factor pathway inhibitor 2 | −1.73241 | 1.967329 | 7 | 7q22 |
| EXTL1 | Exostosin-like glycosyltransferase 1 | −1.27449 | −2.37647 | 1 | 1p36.1 |
| MR1 | major histocompatibility complex, class I-related | 1.173685 | 1.064675 | 1 | 1q25.3 |
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1.752677 | −1.15911 | 1 | 1q42.2 |
| RPL23 | ribosomal protein L23 | 1.819593 | 2.630793 | 17 | 17q |
| TNNC2 | troponin C type 2 (fast) | 2.405029 | 3.232683 | 20 | 20q12-q13.11 |
| SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 2.733915 | 2.305187 | 1 | 1q32.1 |
| B4GALT4 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 | −0.88068 | 1.067247 | 3 | 3q13.3 |
| UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats | 0.669221 | −1.5223 | 15 | 15q22-q24 |
| KIAA1683 | Q Domain-Containing Protein N | 0.875501 | 1.339538 | 19 | 19p13.1 |
| SKP2 | S-phase kinase−associated protein 2, E3 ubiquitin protein ligase | −0.68236 | 0.753601 | 5 | 5p13 |
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.552419 | 0.785465 | 4 | 4q12 |
| RELL2 | RELT-like 2 | 1.337275 | 0.531247 | 5 | 5q31.3 |
| SLC24A1 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 | 0.701308 | 0.546544 | 15 | 15q22 |
Figure 2Relative mRNA expression levels of specific downregulated genes. RT-qPCR results from siCENP-E 72 h and siCENP-E 2 w RNA-interfered IMR90 cells compared to siGFP-transfected cells. The analysis were performed in triplicate. The data presented are the means ± SD (error bar) of fold changes.
Gene sets enriched in CENP-E transient knocked-down IMR90 cells.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| |||||
| Cholesterol Homeostasis | 55 | 0.550825 | 2.219.529 | 0.0 | 0.0 |
| Apoptosis | 128 | 0.29306307 | 14.145.108 | 0.026666667 | 0.17741449 |
|
| |||||
| E2F Targets | 124 | −0.4112242 | −18.818.628 | 0 | 0.001760578 |
| G2/M Checkpoint | 130 | −0.42952272 | −19.638.364 | 0 | 0.001968572 |
| Mitotic Spindle | 132 | −0.33654705 | −15.422.429 | 0 | 0.08193885 |
| Angiogenesis | 25 | −0.44820115 | −14.857.963 | 0.04587156 | 0.100587666 |
| Estrogen Response Late | 160 | −0.30400178 | −14.472.796 | 0.013745705 | 0.11437272 |
| Bile Acid Metabolism | 81 | −0.33262056 | −14.141.632 | 0.028520498 | 0.12994246 |
| Xenobiotic Metabolism | 145 | −0.29437807 | −13.890.945 | 0.036036037 | 0.14013477 |
| Unfolded Protein Response | 74 | −0.31752646 | −13.405.416 | 0.060998153 | 0.14493392 |
| Adipogenesis | 130 | −0.29467914 | −1.363.687 | 0.03345725 | 0.15041217 |
| TNFA Signaling via NFkB | 142 | −0.28777105 | −13.413.501 | 0.041736227 | 0.15983883 |
|
|
|
|
|
|
|
|
| |||||
| Epithelial Mesenchymal Transition | 151 | 0.33510843 | 1.519.574 | 0.0075642965 | 0.11385157 |
| IL6/JAK/STAT Signaling | 58 | 0.37629685 | 14.682.375 | 0.034035657 | 0.11548446 |
| Interferone Gamma Response | 129 | 0.33727473 | 14.752.915 | 0.012403101 | 0.1355435 |
| Hypoxia | 141 | 0.34279573 | 15.343.299 | 0.00147929 | 0.14622506 |
| Xenobiotic Metabolism | 145 | 0.31554386 | 14.156.777 | 0.009036144 | 0.15259206 |
| Coagulation | 100 | 0.32489774 | 13.754.646 | 0.032357473 | 0.16717246 |
| Heme Metabolism | 136 | 0.30528104 | 13.594.577 | 0.03153153 | 0.16950405 |
| Complement | 141 | 0.31029537 | 13.893.101 | 0.02413273 | 0.16991296 |
| Hedgeog Signaling | 24 | 0.41114244 | 13.165.202 | 0.12477396 | 0.17681527 |
| Inflammatory Response | 138 | 0.30268276 | 13.413.032 | 0.052469134 | 0.17737256 |
| UV Response DN | 104 | 0.3095823 | 13.233.161 | 0.046178345 | 0.18309012 |
|
| |||||
| mTORC1 Signaling | 141 | −0.33381698 | −16.185.987 | 0.0 | 0.047431484 |
| P53 Pathway | 135 | −0.34690675 | −16.548.364 | 0.005830904 | 0.06875795 |
| NOTCH Signaling | 24 | −0.45094362 | −14.955.359 | 0.04481132 | 0.09119969 |
| KRAS Signaling UP | 143 | −0.29774994 | −14.312.139 | 0.018018018 | 0.1097472 |
ES: Enrichment Score; NES: Normalized Enrichment Score; FDR: False Discovery Rate.
Figure 3Enrichment plots of the significantly enriched xenobiotic metabolism gene set shared by the two samples. The y-axis show the enrichment scores (ES) and the x-axis shows gene members for the two gene sets. The green line connects points between ES and genes. ES represent the amount to which a gene is over-represented in a gene set. The coloured bands represent positive (red) or negative (blue) degrees of correlation of genes with the siCENP-E (72 h or 2 w) phenotype. The xenobiotic metabolism gene set was negatively correlated (ES = −0.29) with the early siCENP-E timepoint; 26 of 145 genes from this set were downregulated at 72 h with respect to the control. Conversely, the xenobiotic metabolism gene set was positively correlated (ES = 0.31) with the late siCENP-E timepoint and 34 of 145 genes from this set were upregulated at 2 weeks with respect to the control (Tables S5 and S6). Significance threshold set at p-value < 0.05. The enrichment plots were derived from GSEA tool [21].
Hallmark mitotic-spindle-enriched genes in IMR90 siCENP-E 72 h cells.
| Gene Symbol | Description | Running ES |
|---|---|---|
| TIAM1 | T-cell lymphoma invasion and metastasis 1 | −0.32938716 |
| LRPPRC | Leucine-rich PPR-motif-containing | −0.32254452 |
| FSCN1 | fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | −0.31544223 |
| HDAC6 | histone deacetylase 6 | −0.31205016 |
| UXT | Ubiquitously-expressed transcript | −0.3070534 |
| TUBD1 | tubulin, delta 1 | −0.30694872 |
| CKAP5 | Cytoskeleton-associated protein 5 | −0.3005278 |
| TTK | TTK protein kinase | −0.2928824 |
| ARHGAP4 | Rho GTPase-activating protein 4 | −0.29161006 |
| MARCKS | myristoylated alanine-rich protein kinase C substrate | −0.29939783 |
| GEMIN4 | gem (nuclear organelle)-associated protein 4 | −0.29208082 |
| FBXO5 | F-box protein 5 | −0.2945973 |
| ROCK1 | Rho-associated, coiled-coil-containing protein kinase 1 | −0.29402748 |
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | −0.29998654 |
| PXN | Paxillin | −0.30580252 |
| CENPF | centromere protein F, 350/400 ka (mitosin) | −0.29683083 |
| PREX1 | Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Rac Exchanger 1 Protein | −0.29543936 |
| RAB3GAP1 | RAB3 GTPase-activating protein subunit 1 (catalytic) | −0.28851372 |
| CENPJ | centromere protein J | −0.28630605 |
| KIF2C | kinesin family member 2C | −0.27653277 |
| TPX2 | TPX2, microtubule-associated, homolog (Xenopus laevis) | −0.26817042 |
| TSC1 | tuberous sclerosis 1 | −0.2579142 |
| NCK1 | NCK adaptor protein 1 | −0.25523746 |
| ARHGEF3 | Rho guanine nucleotide exchange factor (GEF) 3 | −0.2437383 |
| SYNPO | Synaptopodin | −0.2319448 |
| STK38L | Serine–threonine kinase 38-like | −0.22208665 |
| OPHN1 | oligophrenin 1 | −0.21298712 |
| BUB1 | BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) | −0.20986164 |
| KIF4A | kinesin family member 4° | −0.20093325 |
| ARHGAP29 | Rho GTPase-activating protein 29 | −0.18930057 |
| PRC1 | protein regulator of cytokinesis 1 | −0.17876585 |
| CLASP1 | Cytoplasmic-linker-associated protein 1 | −0.1655671 |
| TOP2A | topoisomerase (DNA) II alpha 170kDa | −0.16242237 |
| RHOF | ras homolog gene family, member F (in filopodia) | −0.14529541 |
| KIF15 | kinesin family member 15 | −0.12773909 |
| PCGF5 | polycomb group ring finger 5 | −0.11064719 |
| NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | −0.09230707 |
| CCNB2 | cyclin B2 | −0.076223895 |
| KIF23 | kinesin family member 23 | −0.058513902 |
| RACGAP1 | Rac GTPase-activating protein 1 | −0.03790126 |
| CENPE | centromere protein E, 312 kDa | −0.018124685 |
| KIF11 | kinesin family member 11 | 0.005052448 |